A phase 1b study of isatuximab plus pomalidomide/dexamethasone in relapsed/refractory multiple myeloma

Mikhael, J; Richardson, P; Usmani, SZ; Raje, N; Bensinger, W; Karanes, C; Campana, F; Kanagavel, D; Dubin, F; Liu, QY; Semiond, D; Anderson, K

Mikhael, J (reprint author), City Hope Canc Ctr, 445 N Fifth St, Phoenix, AZ 85004 USA.; Mikhael, J (reprint author), Int Myeloma Fdn, 445 N Fifth St, Phoenix, AZ 85004 USA.

BLOOD, 2019; 134 (2): 123

Abstract

This phase 1b dose-escalation study evaluated isatuximab plus pomalidomide/dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM).......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索